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Abstract Gastrin transcription i  islet cells is activated by a cis-regulatory sequence ontaining a binding site for the yeast ranscription factor RAP1. 
The DNA-protein interactions between RAP1 protein and the gastrin DNA element determined by methylation i terference assays are identical to 
those of RAP1 and yeast genes. Point mutations inthe gastrin RAP1 binding site, which abolished RAP1 binding, decreased transcriptional activation 
by this sequence. Islet cells revealed a DNA binding protein with RAPl-like binding specificity. These findings upport he conclusion that gastrin 
transcription is activated in mammalian cells by a RAPl-like transcription factor. 
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1. Introduction 
Gene transcription is highly conserved between yeast and 
mammz.lian cells. Not only are general RNA polymerase II
transcripi:en factor components, uch as TFI ID, highly con- 
served [!] but so are gene-specific transcription factors. The 
similarity between yeast HAP2/3 transcription factor and the 
mammalian CCAAT box binding protein, CBP1, is perhaps the 
most striking example of homology between yeast and mam- 
malian transcription factors with a 75% amino acid homology 
in their DNA binding domains [2,3]. It is likely that mammalian 
homologs remain to be identified related to other classes of 
yeast transcription factors. One candidate is the yeast DNA 
binding protein RAP1. RAP1, also known as GRF1 or TURF 
[4,5] is a highly abundant multifunctional DNA binding protein 
which effects both transcriptional ctivation and silencing in 
yeast. The RAP1 binding site at the HMR silent mating-type 
locus is required for full repression of transcription [6-10]. 
RAPI  binding sites are also found upstream of a large number 
of genes including ribosomal and glycolytic enzyme genes acti- 
vating gene transcription [11-14]. RAP1 also binds to ARSs 
(autonomously replicating sequences) and telomeres of yeast 
chromosomes to regulate cell division [10,15]. Since RAP1 reg- 
ulates many biological processes common to yeast and mam- 
malian cells, homologs of RAP1 with conserved DNA binding 
domains could regulate gene transcription i mammalian cells. 
One approach to identifying these factors is to demonstrate hat 
mammalian genes contain RAP1 binding sites in DNA se- 
quences controlling transcription. The gastrin gene is tran- 
siently expressed in fetal pancreatic islet cells and the encoded 
peptide is suggested to be involved in islet cell neogenesis 
[16,17]. This paper reports that both, the rat and human gastrin 
promoter contain a RAP1 binding site within a cis-regulatory 
domain controlling gastrin gene transcription in islet cells. 
Point mutations in this gastrin RAP1 binding site, which abol- 
ished RAP1 binding, also decreased transcriptional ctivation 
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by this sequence. Furthermore, xtracts of islet cells contained 
a DNA binding protein with RAPl- l ike binding specificity. 
2. Materials and methods 
2.1. Cell lines and DNA transfection 
The rat insulinoma (RIN 38A) cell line [18], hamster insulinoma cell 
line (HIT) and rat pituitary cell line GH4 [19] were cultured as de- 
scribed. For transient transfections, subconfluent HIT and GH4 cells 
were transfected in quadruplicates with gastrin-CAT constructs and 
gastrin reporter gene activity measured by assaying CAT enzyme activ- 
ity [20]. 
2.2. Gastrin reporter gene construction 
Synthetic oligonucleotides containing the RAP1 consensus site, sin- 
gle or multiple point mutations inthe RAP1 consensus sequence or the 
nucleotide sequences flanking the RAPI binding site were synthesized 
(Fig. 5) ligated into the NdeI site of the 82 GASCAT reporter gene 
construct [20]. All constructs were confirmed by restriction analysis and 
DNA sequencing. 
2.3. Production of RAP1 prote& and nuclear protein extracts 
The RAP1 protein was cloned from a lamda gtl 1 expression library 
(unpublished results) using the ligand binding technique [21]. Sequenc- 
ing revealed identity with the RAPI sequence r ported [22]. The RAP1 
cDNA fragment containing the RAP1 coding sequence was subcloned 
into the vector pTRA-1, a derivative of pGEM-3Z, which fuses a 
human ~-globin ATG and Kozak sequence in frame with the RAP1 
sequence. The tailored RAP1 clone designated pTRA-RAP1 contained 
the ATG positionned immediately to the SP6 promoter, pTRA-RAP1 
template linerized with XbaI (nucleotide 3670) was transcribed using 
SP6 polymerase under standard conditions (Promega Biotec) in the 
presence of the cap analog m7G5'ppp5'G (Pharmacia, Inc.) and trans- 
lated using the rabbit reticulocyte lysate system (Promega Biotec). 
Mock translation reactions were identical but not primed with RAPI 
RNA. Nuclear protein extracts were prepared as described [23] and 
protein concentration determined by the method of Bradford [24]. 
2.4. Gel retardation assays 
Oligonucleotides used in this study were 5'-GATCCC- 
CACCCCATTCCTCTCGCCTGGACT-3' (hGRD), 5'-GGGATCC 
ACACCCATTrCTCTCGCTGTGGGAGTCTGGCCT-3" (rGRD WT, 
wild type), 5"-GGGATCCACACaCATTTCTCTCGCTGTGGGA 
GTCTGGCCT-3" (rGRD mt, mutant), 5'-GGGATCCTTATATTG- 
CAAAAACCCATCAACCTTGAAAA-3' (HMRE WT, wild type), 
5'-GGGATCCTTATATTGCAAAAACaCATCAACCTr GAAAA- 3' 
(HMRE mt, mutant), (mutant oligonucleotides are in lower-case type, 
RAP1 consensus sequences are underlined, RAPI recognition sites in 
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the noncoding strands are displayed initalics). Single-stranded oligonu- 
cleotides were labeled with [32p]ATP using T4 DNA kinase, hybridized 
with the complementary strands, purified by nondenaturing poly- 
acrylamide gel electrophoresis and recovered on DEAE membranes in
1% agarose gels. Binding reactions using nuclear cell extracts were 
performed as described [20]. Binding reactions with in vitro produced 
protein were performed using 5 pl of in vitro translated RAPI protein 
or mock lysate. 
2.5. Methylation i terference analyses 
Sense and antisense strands of a 80 base pair fragment containing the 
rat gastrin promoter sequence 5'-CACACCCATTTCTCTCGC- 
TGTGGGAGTC-3' (nucleotides -95 to -69) were separately labelled 
using [32p]dATP (3,000 Ci/mmol; Amersham) and Klenow polymerase 
(Bethesda Research Laboratories, Inc.) and treated with 0.25% di- 
methyl sulfate in 50 mM sodium cacodylate, 1 mM EDTA (pH 8.0) for 
5 rain at 22°C to partially methylate the DNA. The fragment was 
recovered by several ethanol precipitations and washed twice with 80% 
ethanol before using in standard binding reaction. The binding reaction 
was electrophoresed through a2% agarose gel in 0.5 × TBE, fragments 
present in complexed and unbound DNA bands recovered into DEAE 
membranes and phenol extracted before piperidine cleavage. The cleav- 
age products from each fragment were separated on a 10% polyacryl- 
amide sequencing gel and detected by autoradiography [25]. The G and 
G + A sequencing reactions were performed as described [26]. 
3. Results 
3.1. The gastrin promoter contains in the islet regulatory domain 
a RAP1 binding sequence 
Comparison of the rat (rGRD, unpublished results) and 
human (hGRD, [20]) gastrin promoter sequences revealed a
high sequence conservation i the islet regulatory domains (Fig. 
la). Furthermore, a good match to the consensus recognition 
sequence for the yeast DNA binding protein RAP1, A(A/ 
C)ACCCANN(C/A)(C/A)Y(C/A), [10,22,27] was observed in 
this conserved promoter egion of the gastrin gene (Fig. lb). 
3.2. Binding of in vitro produced RAP1 protein to the rat gastrin 
promoter sequence 
To test whether RAP1 binds to the rat gastrin islet regulatory 
domain, yeast RAP 1 was translated in vitro using reticulocyte 
lysate programmed by a SP6 RNA polymerase transcript of the 
RAP1 cDNA. Gel mobility shift assays were performed to test 
binding of in vitro translated yeast RAP1 protein to a labelled 
DNA oligonucleotide (rGRD) containing the RAPl-l ike ele- 
ment in the gastrin promoter (Fig. 2). Lysates programmed 
with RAP1 SP6 transcript formed a slowly migrating specific 
(a) hGILD 5" CCCACCCCATFCCrCTCGCCT GGACTC 3' 
rGRD 5" CCACACCCATrTCTCTCGCTGTGGGAGTCTGGCCTC 3" 
(b) RNR2 5' ACACCCAGACCTC 3' 
~K 5' AAACCCAGACACG 3' 
~RD 5' ACACCCATTTCTC 3" 
hGRD 5' CACCCCATTCCTC 3' 
I-I/VlRL 5" AAACCCATCAACC 3' 
HMRE 5" AAACCCATCAACC 3' 
~PlCo~e~ 5" AAACCCANNCATT 3' 
* **  **  
Fig. 1. (a) Sequence comparison of the human gastrin islet regulatory 
element (hGRE, nucleotides -108 to -83) and the corresponding ele- 
ment in the rat gastrin promoter (rGRE; nucleotides -96 to -62). 
Conserved nucleotides are displayed in bold. (b) Sequence alignment 
between RAPI binding sites of RNR2 [38], PGK [13], HMRE, HMLE 
[22], hGRD [20], rGRD. The consensus RAP1 binding site is given in 
bold. Conserved residues are indicated with asterisk. 
Competitor: HMREWT HMRE mt rGRD 
50 150 50 150 50 150 
X X X X X X 
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F • 
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Fig. 2. Demonstration f RAP1 binding to the gastrin islet regulatory 
domain (rGRD). Gel retardation assays were performed using mock 
(lane 1) and RAP1 (lanes 2-8) programmed reticulocyte lysates and the 
rGRD sequence as DNA binding probe (lanes 1-8). Competitor ol- 
igonucleotides included HMRE WT, HMRE mt and rGRD sequences 
in 50- or 150-fold molar excess. A and B indicate DNA-protein com- 
plexes; F, free migrating DNA binding probe. 
protein-DNA complex with the rGRD gastrin DNA probe 
(Fig. 2, lane 2) that was not seen with mock translated lysate 
(Fig. 2, lane 1). RAP1 binding was competed by a 50- and 
150-fold molar excess of unlabelled rGRD gastrin sequence 
(Fig. 2, lanes 7 and 8). Binding was also specifically displayed 
with a 50-fold molar excess of an unlabelled oligonucleotide 
containing the wild type yeast HMRE sequence, a well charac- 
terized RAP1 binding site (Fig. 2, lane 3). However, DNA 
binding was not competed by a 150-fold molar excess of the 
mutant HMRE sequence oligonucleotide (HMRE mt) which 
differs from the wild type sequence by a single base mutation 
ACCCA to ACaCA (Fig. 2a, lane 6). This mutation has been 
shown to prevent RAP1 binding in yeast promoters [8,10]. 
The nucleotide residues int he rGRD DNA element neces- 
sary for RAPI binding were determined by methylation i ter- 
ference analysis. Both, the coding and noncoding strands of the 
rat gastrin regulatory domain were endlabelled to detect con- 
tacts at the G residues opposite to the C residues in the RAP1 
consensus equence (ACCCA). RAP1 makes specific contacts 
with the highly conserved G-C base pairs in the RAP1 consen- 
sus binding site of the noncoding strand of the rat gastrin 
regulatory domain (Fig. 3) similar to that seen in the RAP1 
binding site in the yeast PGK promoter (Fig. lc) [13]. Analysis 
of the coding strand detected no additional DNA/protein con- 
tacts between the rRGD sequence and the recombinant yeast 
transcription factor (Fig. 3). 
3.3. lslet nuclear extracts contain a protein with RAPl-like 
DNA binding activity 
Islet nuclear extracts were examined for RAPl-l ike DNA 
binding activity by gel mobility shift assays using the rGRD 
probe containing the RAP1 recognition site (rGRD WT, Fig. 
1). Binding was also analysed with a mutant gastrin probe 
(rGRD mt, Fig. 1) containing an identical sequence save for the 
single C-A transversion disrupting RAP1 binding. Three com- 
plexes (C1 to C3) were observed using the wild type rat gastrin 
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sequence as probe (Fig. 4, lane 1). Competition with a 50-fold 
excess of unlabelled wild type gastrin sequence rGRD WT 
abolished the upper and middle complexes C1 and C2, while 
the lower complex C3 was only partially displaced (Fig. 4, lane 
2). However, competition with a 50-fold excess of unlabelled 
mutant gastrin sequence, rGRD mt, displaced the middle com- 
plex C2 but not the upper complex C1 (Fig. 4, lane 3). Further- 
more, only complexes C2 and C3 could be resolved when using 
the mutant gastrin sequence rGRD mt as probe, the upper 
complex C1 could not be observed (Fig. 4, lane 4). These find- 
ings support he hypothesis that a DNA binding protein in islet 
cells binds specifically dependent on the RAP1 recognition site 
in the gastrin promoter. 
3.4. The RAP1 element in the gastrin promoter mediates 
activation of gastrin gene transcription in islet cells 
To determine whether the RAP1 binding sequence func- 
tioned as a transcriptional regulatory element, islet and pitui- 
tary tumour cell lines were transfected with gastrin reporter 
gene constructs (RAP-GASCAT). The constructs comprised 
synthetic oligonucleotides of the sequence from -75 to -107 of 
the gastrin gene containing the RAP1 binding site ligated 5' to 
a truncated gastrin reporter gene 82GASCAT [20]. The syn- 
thetic oligonucleotides comprised the wild type sequence or 
F B F G G*A 8 F G G*A 
I> 
t> 
t> 
noncoding 
1 
coding 
v / / / / / / / / / / / / / / / f f l  
5' CACA CCCATTT CTCTC GCTGTGGGAGT C 3' 
3' GTGT GGG TAAAGAGAGCGACACCCT CAG 5' 
A AA& A L~ 
Fig. 3. Methylation i terference of the rGRD-RAPI complex A (Fig. 
2, lane 2). Coding and noncoding strands are displayed. F, free frag- 
ment. B, fragment bound to RAP1. G and G + A refer to Maxam and 
Gilbert sequencing reactions. The positions of the RAPl binding ele- 
ments in the rat gastrin regulatory domain (rGRD) relative to the 
autoradiograph are shown on the left and right side. (3 residues at 
which methylation i terfered with RAP1 binding to the r(3RD are 
indicated with triangles. Solid triangles represent a greater degree of 
interference than open triangles. 
Probe t rGRD WT - - I  rrGRD-I 
mt 
Competitor ,, rGRD rGRD 
WT mt 
C1 
C2 D 
C3 t> 
F • 
1 2 3 4 
Fig. 4. Demonstration f a RAP l-like DNA binding activity in islet cell 
extract. Gel retardation assays using RIN 38A cell extracts and the 
rGRD WT sequence (lanes 1-3) or rGRD mt sequence (lane 4) as 
labelled probes. Unlabelled rGRD WT sequence and rGRD mt se- 
quence were used as competitors in lanes 2 and 3, respectively. C l, C2 
and C3 indicate DNAJprotein complexes. F, free migrating probe. 
mutations in the RAP1 binding site or in residues flanking the 
RAP1 sequence. These constructs were transiently transfected 
into GH4 and HIT cell lines and transcriptional ctivity meas- 
ured by assaying CAT activity (Fig. 5). Mutations within the 
RAP1 binding site decreased reporter gene expression in both 
cell lines in contrast to mutations outside the RAP1 binding site 
which did not decrease reporter gene expression. Furthermore, 
there was a strong quantitative correlation between the strength 
of RAP1 binding and transcriptional ctivity amongst he dif- 
ferent reporter gene mutants. The single C-A point mutation 
in the ACCCA motif, which was the site of strongest methyla- 
tion interference of RAP1 binding (Fig. 3) markedly decreased 
reporter gene activity. Mutations in nucleotides which showed 
weak methylation i terference of RAP1 binding (Fig. 3) only 
weakly decreased reporter gene activity. Point mutations in 
sequences downstream of the RAP1 site in the gastrin promoter 
had only little effect on promoter activity. These data suggest 
that the rat gastrin gene contains a positive cis-regulatory ele- 
ment which binds a transcriptional ctivator protein with se- 
quence specificity similar to the yeast transcription factor 
RAP1. 
4. Discussion 
Many studies have shown that yeast transcription factors 
share both, structural and functional homology with mammal- 
ian transcription factors [28-30]. One feature of this conserva- 
tion is that homologous mammalian and yeast transcription 
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Fig. 5. The RAP1 binding site in the rat gastrin promoter is a positive 
cis-regulatory element. CAT receptor gene xpression i HIT and GH4 
cells transiently transfected with CAT reporter gene constructs with the 
wild type or mutated rat RAP1 binding sites. Reporter gene activity for 
each construct is shown as a percentage of the wild type construct 
activity (mean + S.E.M., n = 4). The wild type sequence is shown at the 
bottom where dark or light asterisks indicate sites of strong or weak 
methylation i terference of RAP1 binding. The nucleotide substitution 
in the mutant constructs are shown above. 
factors recognize identical DNA sequences. Thus, the presence 
of a recognition motif for a yeast ranscription factor within a 
cis-regulatory element of a mammalian promoter may indicate 
that this site is bound by a mammalian homologue of that 
transcription factor. This has been verified by many examples, 
including the TGACTGCA, CAAT and CAnnTG motifs bind- 
ing leucine zipper and helix loop helix proteins [2,31-34]. Al- 
though RAP1 is an abundant multifunctional DNA binding 
protein which regulates highly conserved fundamental eukar- 
yotic functions, no homologue protein has been identified in 
mammalian cells. Recently, however, Pollice et al. [35] reported 
the presence of a RAP1 binding site in the polyoma virus 
enhancer which activated transcriptional activity in yeast cells. 
Similar RAP1 binding sites are also found in the SV40 and BPV 
enhancers. The functional significance of this RAP1 site in the 
polyoma enhancer was not clear since the RAPI site was not 
associated with binding sites for other transcription factors as 
would be anticipated for functional cis-regulatory elements in 
promoters and enhancer ele elements. Furthermore, detection 
of a RAPl-like binding protein in mammalian cells has not 
been reported nor has the RAP1 site been shown to be a 
cis-regulatory element controlling transcription i mammalian 
cells. 
The present study has identified a RAP 1 binding site within 
a cis-regulatory sequence (GRD) which controls gastrin gene 
transcription i islet cells [20]. The RAP1 binding site in the 
gastrin promoter is adjacent to cis-regulatory elements which 
bind transcriptional repressors (ATTCCTCT) or activators 
(CATATGG). This is consistent with previous tudies in yeast 
suggesting that the regulatory function of RAP1 is determined 
by the context of its binding site and, presumably its interaction 
with other factors [36,37]. Gel mobility shift assays and methyl- 
ation interference studies also demonstrated sequence specific 
DNA-protein interactions between the gastrin DNA element 
and recombinant RAP1 protein identical to those reported for 
RAP1 binding sites in yeast promoters. Point mutations within 
the GRD which abolish RAP1 binding reatly decreased tran- 
scriptional ctivity of reporter genes transfected into mammal- 
ian cells, suggesting that mammalian cells express a transcrip- 
tional activator which binds to RAPI binding sites. Gel mobil- 
ity shift assays revealed a specific DNA-protein complex 
formed between GRD DNA sequences containing the RAP1 
gastrin site and a protein in islet cell nuclear extracts. Although 
further characterization f this factor is required to confirm 
RAPl-like properties of this DNA binding protein, these find- 
ings support he hypothesis that mammalian gene transcription 
is activated by homologs of the yeast transcription factor 
RAPI. 
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